Breaking News on Contract Research, Manufacturing & Clinical Trials

Almac discovers novel immune response mechanism

19-Oct-2016 - Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.

News in brief

CordenPharma completes API process bay for category 4 compounds

19-Oct-2016 - This week CordenPharma announced the completion of its new highly potent API process bay for category 4 compounds.

Catalent to manufacture Moderna's personalized cancer vaccine for Ph I/II studies

17-Oct-2016 - Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.

News in brief

CMC Biologics and IDT Biologika expand ADC manufacturing collaboration

13-Oct-2016 - CMC Biologics and IDT Biologika have added Cerbios-Pharma SA and Oncotec Pharma Produktion GmbH to the companies’ PROVEO Partnership – a strategic collaboration for manufacturing antibody drug conjugates (ADCs).

Pfizer on CMOs: $180bn is at stake so being first-to-market is critical

13-Oct-2016 - With the top 500 molecules in development having a commercial potential of $180bn by 2022, being first-to-market is critical says Pfizer.

Dispatches from CPhI Worldwide

Single-use tech will impact the 'extremely consolidated' bio-CMO space, expert

06-Oct-2016 - Lonza and Boehringer-Ingelheim dominate the consolidated biologics CMO space but disposable technologies and improved yields are beginning to change this, says PharmSource’s Jim Miller.

News in brief

CDMO MabPlex expands cGMP manufacturing facilities in China

05-Oct-2016 - MabPlex International is expanding its biomanufacturing facilities in China to meet biologic demand for “the foreseeable future.”

News in brief

Alcami launches supply chain security offering

05-Oct-2016 - Alcami has announced its first to market Protect Your Brand™ offering, which it said will support companies looking to implement a backup supply option.

Compounder Empower opens FDA-registered 503B outsourcing facility

03-Oct-2016 - Empower Pharmacy has opened a new 15,000-square-foot facility as it looks to establish long-term viability in the compounding pharmacy industry.

CRO Pharmaron and MSD reach shared site agreement

27-Sep-2016 - Pharmaron has acquired MSD’s Hoddesdon, UK-based Good Manufacturing Practice (GMP) standard facilities to advance its API and formulation development.

News in brief

Alcami enhances analytical services in Edison, NJ

27-Sep-2016 - The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

Colorcon and Dow extend controlled release alliance

22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

IDT Biologika: trends and demand in first year of US-based contract manufacturing operations

22-Sep-2016 - In its first year of operations, IDT Biologika’s contract manufacturing facility in Rockville, Maryland has experienced rapid growth, which it expects to continue as construction carries on.


Almac: investment to ensure space, staff, larger US footprint

21-Sep-2016 - Yesterday, Almac Group announced a $5.2m investment in its US-based operations, which its global VP of operations said will support customers “across the drug development lifecycle.”

Almac Group announces $5.2m expansion

20-Sep-2016 - In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

News in brief

CDMO Custom Pharma Services expands operations

20-Sep-2016 - The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.


Promising Korea? CMO giant Samsung Biologics opens doors to Biopharma-Reporter

16-Sep-2016 - Since 2011, Samsung Biologics has built two plants, gained Bristol-Myers Squibb and Roche as clients and launched an IPO. With a third facility under construction, Biopharma-Reporter visited to see the...

Lonza licenses rights to sell synthetic AAVs to gene therapy developers

14-Sep-2016 - Lonza has licensed rights to synthetic adeno-associated viral (AAV) vectors developed by scientists at US hearing research centre, Massachusetts Eye and Ear.

Catalent to plug bioavailability tech gap with Pharmatek Laboratories buy

13-Sep-2016 - Catalent has announced its intention to buy Pharmatek Laboratories to boost its drug bioavailability offering.

AGC leaps into microbial CMO space through Biomeva acquisition

13-Sep-2016 - Japanese glass solution provider AGC Asahi Glass has bought Germany’s Biomeva in a bid to launch itself into the international microbial CMO space.

Avid to construct third plant with two 1,000L single-use bioreactors

13-Sep-2016 - Avid Bioservices will construct a clinical manufacturing plant later this year just months after production began at a second facility.

LI-COR expansion offers early-phase cGMP services

12-Sep-2016 - LI-COR Biosciences has expanded its production facility to offer contract manufacturing for early-phase cGMP materials.

Spain's Idifarma bolstered by investment from API maker Suanfarma

12-Sep-2016 - Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.

Cambrex investment continues as industry trends ‘remain favorable’

07-Sep-2016 - The latest in a series of investments, Cambrex has recently expanded its Sweden-based site as part of its ongoing investment in small molecule API manufacturing across its global network of...

AMRI expects to make layoffs during Euticals integration

07-Sep-2016 - AMRI has said integrating recent Italian acquisition Prime European Therapeuticals, also known as Euticals, will involve layoffs.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...